September 2024
1. HOSOKAWA A, Tamura H, Ichihara A, Imamura N, et al
   Pathological Complete Response to Liver Metastasis With Pembrolizumab in a Previously Treated Patient With Microsatellite Instability-high Colorectal Cancer.
   Anticancer Res. 2024;44:4119-4125.
   

   >> Share

   
   
2. SHIRAISHI T, Yamaguchi A, Shibasaki Y, Osone K, et al
   Risk Factors of Poor Outcomes After Colorectal Cancer Surgery for Patients With Severe Comorbidities.
   Anticancer Res. 2024;44:4073-4083.
   

   >> Share

   
   
3. COZZANI F, Ricchiuto M, Virgilio E, Viani L, et al
   The Controlling Nutritional Status (CONUT) Score Predicts Post-operatory Risks and Prognosis in Patients With Surgically Treated Colon Cancer: A Retrospective Study.
   Anticancer Res. 2024;44:3955-3964.
   

   >> Share

   
   
4. JINNO T, Yamaguchi J, Ogura A, Kokuryo T, et al
   Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer.
   Anticancer Res. 2024;44:3757-3769.
   

   >> Share

   
   
5. FUKUSHIMA G, Sato E, Udo R, Tago T, et al
   Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma.
   Anticancer Res. 2024;44:3899-3906.
   

   >> Share

   
   
6. KAYANO H, Mamuro N, Kamei Y, Ogimi T, et al
   Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer.
   Anticancer Res. 2024;44:4019-4029.
   

   >> Share

   
   
7. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
   Simultaneously Detected Liver and Lung Metastases from Colorectal Carcinoma: A Potential Treatment Strategy.
   Anticancer Res. 2024;44:3945-3954.
   

   >> Share

   
   August 2024
8. KAMADA T, Furukawa K, Takahashi J, Aida T, et al
   Preoperative Vertebral Fracture: A Prognostic Factor in Stage I-III Colorectal Cancer.
   Anticancer Res. 2024;44:3533-3541.
   

   >> Share

   
   
9. YOKOTA Y, Nozawa H, Sonoda H, Yokoyama Y, et al
   Indoleamine 2,3-Dioxygenase Inhibitor Suppresses Colon Cancer Cell Migration, Invasion, and Epithelial-Mesenchymal Transition.
   Anticancer Res. 2024;44:3337-3342.
   

   >> Share

   
   
10. TSUJIO G, Fukuoka T, Sugimoto A, Yonemitsu K, et al
    The Efficacy of Chemical Bowel Preparation Against Incisional Surgical Site Infection in Colorectal Cancer Surgery: A Propensity Score Matching Study.
    Anticancer Res. 2024;44:3473-3480.
    

    >> Share

    
    
11. FUKUDA J, Sudo T, Kikuchi M, Kawahara A, et al
    Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer.
    Anticancer Res. 2024;44:3567-3575.
    

    >> Share

    
    
12. TAKAHASHI H, Kojima D, Wada H, Hanaoka K, et al
    A Bridge to Curative Surgery for Obstructive Colorectal Cancer: Self-expandable Metallic Stent Versus Decompression Tube.
    Anticancer Res. 2024;44:3427-3441.
    

    >> Share

    
    
13. MUKOHYAMA J, Koizumi M, Yamashita K, Yoshimi A, et al
    Knockdown of CDX2 Induces microRNA-221 Up-regulation in Human Colon Cancer Cells.
    Anticancer Res. 2024;44:3553-3556.
    

    >> Share

    
    July 2024
14. KOMORI K, Yoshida M, Tsukushi S, Kinoshita T, et al
    Combined Pubic Arch and Ischial Bone Resection for Metachronous and Frequent Local Recurrences of Rectal Cancer.
    Anticancer Res. 2024;44:3205-3211.
    

    >> Share

    
    
15. LEE SH, Kim SA, Park SJ, Lee MY, et al
    NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity Against SW480 Colorectal Cancer Cells.
    Anticancer Res. 2024;44:2909-2919.
    

    >> Share

    
    
16. SHIOI I, Ogawa H, Naito R, Endo M, et al
    Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer.
    Anticancer Res. 2024;44:3013-3023.
    

    >> Share

    
    
17. TSUMURAYA H, Mimura K, Nakajima S, Hanayama H, et al
    Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:2933-2941.
    

    >> Share

    
    
18. KARLIKOVA M, Curillova M, Pecen L, Karnos V Jr, et al
    Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
    Anticancer Res. 2024;44:3105-3113.
    

    >> Share

    
    June 2024
19. MOON SU, Lee JH, Shah M, Yoon S, et al
    RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.
    Anticancer Res. 2024;44:2471-2485.
    

    >> Share

    
    
20. TOREN W, Sasor A, Ansari D, Andersson R, et al
    ARHGAP4 as a Prognostic Biomarker for Colon Liver Metastases After Surgical Resection.
    Anticancer Res. 2024;44:2597-2604.
    

    >> Share

    
    
21. MATSUDA A, Yamada T, Takahashi G, Matsumoto S, et al
    Significance of Adjuvant Chemotherapy for Obstructive Colorectal Cancer After Stent Placement: A Multicenter Retrospective Study.
    Anticancer Res. 2024;44:2737-2745.
    

    >> Share

    
    
22. LIM SC, Lee TB, Han SI
    Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells.
    Anticancer Res. 2024;44:2587-2595.
    

    >> Share

    
    May 2024
23. WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al
    Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
    Anticancer Res. 2024;44:2177-2183.
    

    >> Share

    
    April 2024
24. WU CC, Su CC, Chen YH, Hsu CW, et al
    Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2024;44:1619-1628.
    

    >> Share

    
    
25. TANAKA H, Hayashi H, Tomita H, Tokumaru Y, et al
    Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
    Anticancer Res. 2024;44:1611-1618.
    

    >> Share

    
    
26. SHIRAISHI T, Tominaga T, Ono R, Noda K, et al
    Short- and Long-term Outcomes After Colonic Stent Insertion as a Bridge to Surgery in Elderly Colorectal Cancer Patients.
    Anticancer Res. 2024;44:1637-1643.
    

    >> Share

    
    
27. SYRJANEN K, Eskelinen M, Meklin J, Hendolin P, et al
    Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB).
    Anticancer Res. 2024;44:1513-1523.
    

    >> Share

    
    
28. BEPPU T, Yamamura K, Masuda T, Miyamoto H, et al
    High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Anticancer Res. 2024;44:1533-1539.
    

    >> Share

    
    
29. SATOYOSHI T, Hirohashi Y, Okuya K, Miyo M, et al
    CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.
    Anticancer Res. 2024;44:1603-1610.
    

    >> Share

    
    
30. AOYAMA T, Yukawa N, Saito A
    Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment.
    Anticancer Res. 2024;44:1335-1351.
    

    >> Share

    
    March 2024
31. ZHENG W, Chen K, Lv Y, Lao W, et al
    Pyrvinium Pamoate Induces Cell Apoptosis and Autophagy in Colorectal Cancer.
    Anticancer Res. 2024;44:1193-1199.
    

    >> Share

    
    
32. EBATA Y, Nakanishi R, Tanaka Y, Kawazoe T, et al
    Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
    Anticancer Res. 2024;44:1281-1287.
    

    >> Share

    
    
33. HARA S, Sakai D, Ikemura K, Shintani T, et al
    Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer.
    Anticancer Res. 2024;44:1219-1226.
    

    >> Share

    
    
34. SILVA EF, Fernandes BN, Marinello P, Deminice R, et al
    Pre and Post-high-intensity Interval Training Delays Colon Tumor Onset in a Syngeneic Mouse Model.
    Anticancer Res. 2024;44:1209-1217.
    

    >> Share

    
    
35. HEGEDUS D, Szemeredi N, Gabor M, Sas J, et al
    Cyclic Amines Coupled to Indole Derivatives With Improved Efflux Pump Inhibiting Activity in Bacteria and Cancer Cells.
    Anticancer Res. 2024;44:1149-1160.
    

    >> Share

    
    
36. ARDJMAND D, Kubota Y, Sato M, Han Q, et al
    Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells.
    Anticancer Res. 2024;44:929-933.
    

    >> Share

    
    February 2024
37. OGAWA H, Shiraishi T, Okada T, Miyamae Y, et al
    Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer.
    Anticancer Res. 2024;44:805-814.
    

    >> Share

    
    
38. NAKAMURA S, Kageyama H, Torii K, Hishida M, et al
    High-risk Features for Recurrence in Patients With Stage III Colorectal Cancer: A Retrospective Cohort Study.
    Anticancer Res. 2024;44:757-766.
    

    >> Share

    
    
39. NONAKA K, Nakanishi R, Nambara S, Jiang HQ, et al
    Clinicopathological Impact of High Preoperative CA19-9 in Early-stage Colorectal Cancer: A Single-center Retrospective Cohort Study.
    Anticancer Res. 2024;44:797-803.
    

    >> Share

    
    
40. ZHENG H, Tsunedomi R, Xu M, Zhang Y, et al
    Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis.
    Anticancer Res. 2024;44:511-520.
    

    >> Share

    
    
41. YAMAMOTO A, Shimizu H, Takiguchi K, Shoda K, et al
    The Expression and Role of Aquaporin 4 in Colon Cancer.
    Anticancer Res. 2024;44:567-573.
    

    >> Share

    
    
42. NAKAYAMA T, Furuya S, Higuchi Y, Matsuoka K, et al
    Investigating Cytoglobin Expression in Colon Cancer: Clinicopathological Insights from Immunohistochemical Analysis.
    Anticancer Res. 2024;44:561-565.
    

    >> Share

    
    
43. KOBAYASHI Y, Uemura M, Paku M, Kitakaze M, et al
    Venous Thromboembolism Following Lateral Lymph Node Dissection for Rectal Cancer.
    Anticancer Res. 2024;44:695-701.
    

    >> Share

    
    
44. KOMORI K, Kinoshita T, Sato Y, Ouchi A, et al
    Novel Repair Technique for Oral and Anal Side Stoma Prolapse of a Loop Colostomy With the Stapled Modified Altemeier Method Using Indocyanine Green Fluorescence Imaging.
    Anticancer Res. 2024;44:853-857.
    

    >> Share

    
    
45. KE TW, Zwane ST, Chiang SF, Chen TW, et al
    Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal Adenocarcinoma.
    Anticancer Res. 2024;44:787-796.
    

    >> Share

    
    
46. IMAOKA K, Ohira M, Shimomura M, Hattori M, et al
    Effect of Abdominal Aortic Calcification on Recurrence Following Initial Hepatectomy for Colorectal Liver Metastases.
    Anticancer Res. 2024;44:649-658.
    

    >> Share

    
    January 2024
47. KIM JH, Cha Y, Shin SJ, Park YS, et al
    Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study.
    Anticancer Res. 2024;44:347-359.
    

    >> Share

    
    
48. NAKANISHI T, Matsuda T, Yamashita K, Hasegawa H, et al
    Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
    Anticancer Res. 2024;44:229-237.
    

    >> Share

    
    
49. SATO M, Han Q, Kubota Y, Baranov A, et al
    Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer.
    Anticancer Res. 2024;44:31-35.
    

    >> Share

    
    
50. LIM YJ, Kong M
    Role of Radical Surgery Following Preoperative Chemoradiotherapy in Octogenarians With Rectal Cancer: A SEER Analysis.
    Anticancer Res. 2024;44:417-425.
    

    >> Share

    
    
51. JIANG M, Liu Y, Xu J, Xu Z, et al
    Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer.
    Anticancer Res. 2024;44:117-131.
    

    >> Share

    
    
52. ESKELINEN M, Meklin J, Guimaraes DP, Selander T, et al
    The Diagnostic Accuracy (DA) of ColonView Fecal Immunochemical Test (FIT) in Detecting Colorectal Adenoma (CRA) Can Be Improved by the Diagnostic Models (DM) that Include Triage and Risk Features of CRA.
    Anticancer Res. 2024;44:173-184.
    

    >> Share

    
    
53. GOSHIMA T, Ieguchi K, Onishi N, Shimizu T, et al
    Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model.
    Anticancer Res. 2024;44:23-29.
    

    >> Share

    
    December 2023
54. MATSUBARA D, Soga K, Ikeda J, Konishi T, et al
    Laparoscopic Surgery for Elderly Colorectal Cancer Patients With High American Society of Anesthesiologists Scores.
    Anticancer Res. 2023;43:5637-5644.
    

    >> Share

    
    
55. ESKELINEN M, Meklin J, Guimaraes DP, Selander T, et al
    Triage Process at Endoscopy With ColonView Fecal Immunochemical Test (FIT) Will Enhance Diagnostic Accuracy (DA) of Colorectal Cancer Screening.
    Anticancer Res. 2023;43:5535-5544.
    

    >> Share

    
    
56. KUBOYAMA YU, Ishizaki T, Mazaki J, Kasahara K, et al
    Three-dimensional Computed Tomography Evaluation of the Vasculature of Right-side Colon Cancer.
    Anticancer Res. 2023;43:5621-5628.
    

    >> Share

    
    
57. KOBAYASHI A, Ikemura K, Wakai E, Kondo M, et al
    Proton Pump Inhibitors Ameliorate Oxaliplatin-induced Peripheral Neuropathy: Retrospective Analysis of Two Real-world Clinical Databases.
    Anticancer Res. 2023;43:5613-5620.
    

    >> Share

    
    
58. KE TW, Chang SC, Liao YM, Lin CH, et al
    Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study.
    Anticancer Res. 2023;43:5713-5722.
    

    >> Share

    
    
59. TANIGUCHI SH, Komine K, Takenaga N, Yoshida Y, et al
    FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma.
    Anticancer Res. 2023;43:5699-5704.
    

    >> Share

    
    
60. WANG L, Cai X, Chen Y, Hirano Y, et al
    Should pT2N+ Colorectal Cancer Be Downstaged from IIIA to IIA?
    Anticancer Res. 2023;43:5681-5688.
    

    >> Share

    
    
61. TERAISHI F, Shigeyasu K, Kondo Y, Kagawa S, et al
    Clinical Impact of Prehabilitation on Elective Laparoscopic Surgery in Frail Octogenarians With Colorectal Cancer.
    Anticancer Res. 2023;43:5597-5604.
    

    >> Share

    
    
62. NAKAJO S, Uemura M, Sekido Y, Hata T, et al
    Laparoscopic Colorectal Cancer Surgery for Patients With Severe Chronic Heart Failure.
    Anticancer Res. 2023;43:5645-5648.
    

    >> Share

    
    
63. LIN HW, Shih TW, Amanna A, Chang MS, et al
    PHRF1 Promotes Cell Invasion by Modulating SOX4 Expression in Colorectal Cancer HCT116-p53(-/-) Cells.
    Anticancer Res. 2023;43:5437-5446.
    

    >> Share

    
    
64. ZHANG XW, Mohr J, Halama N, Koschny R, et al
    Analysis of an Unselected Patient Cohort With Advanced Colorectal Carcinoma from a Maximum Care Center.
    Anticancer Res. 2023;43:5589-5596.
    

    >> Share

    
    November 2023
65. YOSHIDA T, Homma S, Ichikawa N, Fujiyoshi S, et al
    Feasibility of Laparoscopic and Robotic Total Proctocolectomy for Ulcerative Colitis-related Colorectal Cancer.
    Anticancer Res. 2023;43:5245-5252.
    

    >> Share

    
    
66. WU CC, Su CC, Chen YH, Hsu CW, et al
    Comparative Effectiveness of Cetuximab Versus Panitumumab in Patients With Metastatic Colorectal Cancer: A Nationwide Database Study.
    Anticancer Res. 2023;43:5127-5138.
    

    >> Share

    
    
67. RUBIO CA, Matek C, Vieth M, Lang-Schwarz C, et al
    Sporadic Colorectal Tubular Adenomas Thrive in Symbiosis With Underlying Nondysplastic Branching Crypts.
    Anticancer Res. 2023;43:4947-4952.
    

    >> Share

    
    
68. MIZUUCHI Y, Tanabe Y, Nagayoshi K, Tamura K, et al
    Revisiting the Prognostic Impact of Family History in Colorectal Cancer by Retrospective Propensity Score Matching.
    Anticancer Res. 2023;43:5167-5172.
    

    >> Share

    
    
69. TAKIGUCHI N, Uemura M, Kitakaze M, Paku M, et al
    High Level Sacral Bone Resection for Locally Recurrent Rectal Cancer.
    Anticancer Res. 2023;43:5061-5066.
    

    >> Share

    
    
70. HUANG YN, Chen SC, Chen JC, Liu KW, et al
    Elucidating the Cancer Phenotype in Turner Syndrome: A 20-Year Observational Cohort Study.
    Anticancer Res. 2023;43:5073-5081.
    

    >> Share

    
    
71. MYUNG DS, Oh HH, Kim JS, Lim JW, et al
    Cytochrome P450 Family 46 Subfamily A Member 1 Promotes the Progression of Colorectal Cancer by Inducing Tumor Cell Proliferation and Angiogenesis.
    Anticancer Res. 2023;43:4915-4922.
    

    >> Share

    
    
72. YAMAMOTO S, Fujii H, Murayama K, Iihara H, et al
    Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2023;43:5099-5105.
    

    >> Share

    
    October 2023
73. CHUSANGNIN P, Muangthong T, Payuhakrit W, Palipoch S, et al
    Vitamin C Improves the Inhibitory Effects of Oxaliplatin on HCT-116 Colorectal Cancer Growth and Progression Through Cellular Oxidant Function-associated Cadherin Molecules.
    Anticancer Res. 2023;43:4461-4472.
    

    >> Share

    
    
74. GARRETT C, Cristaudo A, Barat S, Morris DL, et al
    Increased Incidence of Liver Metastases in Colorectal Versus Appendiceal Adenocarcinoma Peritonectomy Patients Despite Equivocal Survival.
    Anticancer Res. 2023;43:4657-4662.
    

    >> Share

    
    
75. KATAOKA M, Kitazawa M, Nakamura S, Koyama M, et al
    Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS(G12D) Inhibitor, in Colorectal Cancer Treatment.
    Anticancer Res. 2023;43:4341-4348.
    

    >> Share

    
    
76. ARIMA K, Uemura N, Tsuneyoshi K, Fujita H, et al
    Microsatellite Instability-high Signet Ring Cell Carcinoma of the Colon Treated With Immunotherapy: Report of a Case.
    Anticancer Res. 2023;43:4729-4733.
    

    >> Share

    
    September 2023
77. KIKUCHI R, Sasaki K, Nozawa H, Murono K, et al
    Prognosis of Inferior Mesenteric and Para-aortic Lymph Node Metastases in Rectal Cancer: A Multicenter Study.
    Anticancer Res. 2023;43:4213-4219.
    

    >> Share

    
    
78. SONG B, Wang L, Chen Y, Hirano Y, et al
    The Significance of Skip Lymph Node Metastasis in Colorectal Cancer.
    Anticancer Res. 2023;43:4169-4177.
    

    >> Share

    
    
79. OZAKI K, Sasaki K, Abe H, Nozawa H, et al
    Apoptosis-related Prognostic Factors in Advanced Colorectal Cancer Determined Using Tissue Microarrays.
    Anticancer Res. 2023;43:3935-3942.
    

    >> Share

    
    
80. MINOJI T, Takahashi H, Watabe T, Ishikawa S, et al
    The Clinical Potential of FBPA-PET/CT Imaging for Colorectal Cancer and its Liver Metastases Expressing LAT1.
    Anticancer Res. 2023;43:3913-3921.
    

    >> Share

    
    
81. ROSENBROCK J, Lieser A, Ostermann-Myrau J, Judge M, et al
    Efficacy and Toxicity of Robotic Stereotactic Body Radiotherapy of Lung Metastases in Patients With Oligometastatic Disease.
    Anticancer Res. 2023;43:4125-4131.
    

    >> Share

    
    
82. DENG Y, Ke TW, Wang YC, Chin YT, et al
    Impact of Matrix Metalloproteinase-8 Genotypes on Colorectal Cancer Risk in Taiwan.
    Anticancer Res. 2023;43:3979-3985.
    

    >> Share

    
    August 2023
83. MUKOHYAMA J, Agawa K, Yamashita K, Matsuda T, et al
    CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer.
    Anticancer Res. 2023;43:3763-3767.
    

    >> Share

    
    
84. BARAT S, Wijayawardana R, Morris D
    Outcomes for Colorectal Cancer Cases With Peritoneal Metastases Treated With Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A Comparative Analysis of Survival Between Peritoneal Carcinomatosis Scores - PCI in a Single
    Anticancer Res. 2023;43:3529-3538.
    

    >> Share

    
    
85. NAKANE H, Sudo T, Kawahara A, Yomoda T, et al
    Simplified and Optimized Immune Score for Colorectal Cancer Microenvironment.
    Anticancer Res. 2023;43:3793-3798.
    

    >> Share

    
    
86. KATAGIRI M, Sudo T, Tounann T, Kakuma T, et al
    Development of an Algorithm to Predict Recurrences After Resection of Liver Metastases in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2023;43:3807-3816.
    

    >> Share

    
    
87. ISHIKAWA T, Imai M, Sato R, Jimbo R, et al
    Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.
    Anticancer Res. 2023;43:3647-3651.
    

    >> Share

    
    
88. YOSHIMITSU K, Mori S, Tanabe K, Wada M, et al
    Transanal Total Mesorectal Excision Considering the Embryology Along the Fascia in Rectal Cancer Patients.
    Anticancer Res. 2023;43:3597-3605.
    

    >> Share

    
    
89. YOSHIDA K, Nishi K, Ishikura S, Matsumoto T, et al
    Inhibitory Effect of Pyra-Metho-Carnil on Cancer Spheroid Growth Through Decrease in Glycolysis-associated Molecules.
    Anticancer Res. 2023;43:3717-3726.
    

    >> Share

    
    
90. ESKELINEN M, Meklin J, Guimaraes DP, Selander T, et al
    Fecal Immunochemical Test (FIT) in Triage of Bleed-positive (Crab+) and Bleed-negative Colorectal Adenoma (Crab-) Patients in Colorectal Neoplasia Screening.
    Anticancer Res. 2023;43:3517-3528.
    

    >> Share

    
    
91. SUGIMOTO K, Takahashi H, Yuki 2nd, Irie T, et al
    Positive Circumferential Resection Margin in Rectal Cancer Is a Robust Predictor of Poor Long-term Prognosis With Clinicopathological Bias Between Groups Compensated by Propensity-score Matching Analysis.
    Anticancer Res. 2023;43:3623-3630.
    

    >> Share

    
    
92. HIRAKAWA H, Sakai H, Kanno H, Goto Y, et al
    Significance of Desmoplastic Histopathological Growth Pattern for Colorectal Liver Metastases Treated With Preoperative Chemotherapy.
    Anticancer Res. 2023;43:3727-3733.
    

    >> Share

    
    July 2023
93. ISHIZAKI T, Mazaki J, Kasahara K, Udo R, et al
    Learning Curve of Intracorporeal Anastomosis in Laparoscopic Colectomy for Right Side Colon Cancer: A Cumulative Sum Analysis.
    Anticancer Res. 2023;43:3341-3348.
    

    >> Share

    
    
94. YOSHIMATSU K, Kono T, Satake M, Ito Y, et al
    Poor Prognosis in Patients With Stage III Colorectal Cancer Receiving Adjuvant FOLFOX/CAPOX Therapy Is Predicted by the Presence of Many Poorly Differentiated Clusters.
    Anticancer Res. 2023;43:3235-3240.
    

    >> Share

    
    
95. MAYANAGI S, Oba K, Aoyama T, Tanaka K, et al
    Feasibility and Safety of Adjuvant Chemotherapy for Resected Colorectal Cancer in Patients With Renal Insufficiency: A Pooled Analysis of Individual Patient Data from Five Japanese Large-scale Clinical Trials.
    Anticancer Res. 2023;43:3089-3095.
    

    >> Share

    
    
96. KAWASHIMA J, Yamagishi S, Mori K
    Usefulness of 3D-CT Angiography to Determine the Extent of Lymphadenectomy in Colon Cancer of the Splenic Flexure.
    Anticancer Res. 2023;43:3295-3303.
    

    >> Share

    
    
97. ZOR DS, Hakan MT, Ozgur E, Horozoglu C, et al
    Plasma Levels of Kynurenine, Soluble OX40 and Mir-138-5p Are Associated With Tumor-infiltrating Lymphocytes in Colorectal Cancer: An Exploratory Study.
    Anticancer Res. 2023;43:3281-3288.
    

    >> Share

    
    
98. YOSHIDA D, Sugiyama M, Nakazono K, Oyama T, et al
    Oncological Impact of the Level of Inferior Mesenteric Artery Ligation in Low Rectal Cancer Surgery.
    Anticancer Res. 2023;43:3225-3233.
    

    >> Share

    
    
99. SHIRAISHI T, Ogawa H, Yamaguchi A, Shioi I, et al
    Two-team Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection Using Transanal Approach for Rectal Cancer: A Retrospective Study.
    Anticancer Res. 2023;43:3311-3319.
    

    >> Share

    
    
100. TAN CQY, Ho A, Robinson HA, Huang L, et al
     A Systematic Review of Microwave Ablation for Colorectal Pulmonary Metastases.
     Anticancer Res. 2023;43:2899-2907.
     

     >> Share

     
     June 2023
101. YUN CW, Lee JH, Lee SH
     Casein Kinase 2alpha Augments Oxaliplatin Resistance in Colorectal Cancer Cells by Increasing ABCE1 Expression.
     Anticancer Res. 2023;43:2519-2525.
     

     >> Share

     
     
102. LA FRANCA A, Muttillo EM, Madaffari I, Massimi F, et al
     Lymph Node Metastasis in Extraperitoneal Rectal Cancer After Neoadjuvant Therapy: An Unsolved Problem?
     Anticancer Res. 2023;43:2813-2820.
     

     >> Share

     
     
103. TAKIGUCHI K, Shimizu H, Shoda K, Shiraishi K, et al
     The Expression and Role of NADPH Oxidase 2 in Colon Cancer.
     Anticancer Res. 2023;43:2601-2608.
     

     >> Share

     
     
104. TAKAKUSAGI Y, Koge H, Kano K, Shima S, et al
     Safety of Carbon-ion Radiotherapy for Prostate Cancer After Rectal Cancer Surgery.
     Anticancer Res. 2023;43:2691-2695.
     

     >> Share

     
     
105. AKAGI H, Tanaka Y, Wada K, Takahashi M, et al
     CDX2-positive Cancer of Unknown Primary With Upper-body Paralysis Was Dramatically Improved by Colorectal Cancer Chemotherapy.
     Anticancer Res. 2023;43:2879-2884.
     

     >> Share

     
     
106. HAYASHI K, Furuta M, Furusawa K, Hamaguchi T, et al
     Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer.
     Anticancer Res. 2023;43:2831-2840.
     

     >> Share

     
     May 2023
107. KIM IS, Cho SY, Yang M, Han S, et al
     ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma.
     Anticancer Res. 2023;43:1943-1957.
     

     >> Share

     
     
108. NAKAGAWA R, Kumamoto T, Maeda F, Tani K, et al
     New Scale Predicting Distant Recurrence in Locally Advanced Lower Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
     Anticancer Res. 2023;43:2179-2184.
     

     >> Share

     
     
109. MIYASHITA S, Shimizu T, Ishizuka M, Niki M, et al
     N2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur-uracil/leucovorin.
     Anticancer Res. 2023;43:2219-2225.
     

     >> Share

     
     
110. HUANG CI, Huang YK, Lee HM, Chen JH, et al
     Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells.
     Anticancer Res. 2023;43:1933-1941.
     

     >> Share

     
     
111. MATSUOKA S, Fujii H, Iihara H, Ohata K, et al
     Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy.
     Anticancer Res. 2023;43:2351-2357.
     

     >> Share

     
     
112. RYU S, Kitagawa T, Goto K, Nagashima A, et al
     Transanal Total Mesorectal Excision for Extended Surgery in the Early Stage After Introduction.
     Anticancer Res. 2023;43:2211-2217.
     

     >> Share

     
     
113. NAKAI N, Maeda A, Yanagita T, Suzuki T, et al
     Elevated Preoperative Serum Vascular Endothelial Growth Factor Does Not Predict Poor Outcomes in Curatively Resected Non-metastatic Colorectal Cancer Treated Without Neoadjuvant Therapy.
     Anticancer Res. 2023;43:2333-2341.
     

     >> Share

     
     
114. FUKUDA S, Niisato Y, Tsuji M, Fukuda S, et al
     Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment.
     Anticancer Res. 2023;43:2085-2090.
     

     >> Share

     
     
115. ORLANDI E, Romboli A, Citterio C, Trubini S, et al
     Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment.
     Anticancer Res. 2023;43:2015-2024.
     

     >> Share

     
     April 2023
116. SATO K, Kasajima H, Imaizumi K, Kurushima M, et al
     Visualization of Anorectal Lymphatic Flow Using Indocyanine Green Fluorescence Imaging: An Observational Study.
     Anticancer Res. 2023;43:1591-1598.
     

     >> Share

     
     
117. DORMAN K, Zhang D, Kunz WG, Angele M, et al
     Treatment of Mediastinal Endometrial Carcinoma Developed from Extragenital Endometriosis and Simultaneous Rectal Adenocarcinoma in a 55-year-old Woman.
     Anticancer Res. 2023;43:1857-1861.
     

     >> Share

     
     
118. CHINCZEWSKI L, Feldhaus FW, Schmitt W, Braicu I, et al
     Complete Response to Immune Checkpoint Inhibition in a Platinum Resistant Primary Ovarian Cancer Patient With Lynch Syndrome: A Case Report and Review of the Literature.
     Anticancer Res. 2023;43:1655-1662.
     

     >> Share

     
     
119. KE TW, Chang SC, Chen HC, Wang HM, et al
     Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort Study.
     Anticancer Res. 2023;43:1843-1851.
     

     >> Share

     
     
120. BYUN J, Park NJ, Yoon G, Kang MK, et al
     PIK3CA Mutations as a Prognostic Factor in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
     Anticancer Res. 2023;43:1513-1520.
     

     >> Share

     
     
121. ASAKO K, Hayama T, Hashiguchi Y, Miyata T, et al
     Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer.
     Anticancer Res. 2023;43:1563-1568.
     

     >> Share

     
     
122. KIM H, Kim HS
     Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing.
     Anticancer Res. 2023;43:1785-1795.
     

     >> Share

     
     
123. ESKELINEN M, Meklin J, Guimaraes DP, Selander T, et al
     Diagnostic Accuracy of Fecal Immunochemical Test (FIT) in Bleed-positive and Bleed-negative Colorectal Cancer (CRC) Among a Cohort of 5,090 Subjects who Participated in the Colorectal Neoplasia (CRN) Screening in Brazil.
     Anticancer Res. 2023;43:1569-1580.
     

     >> Share

     
     March 2023
124. KOBUCHI S, Tsuda M, Okamura M, Nakamura T, et al
     A Pharmacokinetic-Pharmacodynamic Model Predicts Uracil-tegafur Effect on Tumor Shrinkage and Myelosuppression in a Colorectal Cancer Rat Model.
     Anticancer Res. 2023;43:1121-1130.
     

     >> Share

     
     February 2023
125. XU M, Tsunedomi R, Kiyotani K, Tomochika S, et al
     Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal Cancer.
     Anticancer Res. 2023;43:613-620.
     

     >> Share

     
     
126. PAIAR F, Gabelloni M, Pasqualetti F, Cocuzza P, et al
     Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer.
     Anticancer Res. 2023;43:781-788.
     

     >> Share

     
     
127. FERRARI C, Cuniolo L, Mascherini M, Santoliquido M, et al
     Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival.
     Anticancer Res. 2023;43:765-771.
     

     >> Share

     
     
128. WEBER F, Jung R, Treeck O, Buechler C, et al
     Chemerin and Chemokine-like Receptor 1 Are Not Prognostic in Colorectal Carcinoma.
     Anticancer Res. 2023;43:831-839.
     

     >> Share

     
     January 2023
129. SHIRAISHI T, Ogawa H, Yamaguchi A, Saito H, et al
     Relationship Between C-reactive Protein-to-albumin Ratio Before and After Bowel Decompression and Prognosis in Acute Malignant Large Bowel Obstruction.
     Anticancer Res. 2023;43:259-267.
     

     >> Share

     
     
130. BRENNER B, Stern Y, Gordon N, Fuks T, et al
     Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study.
     Anticancer Res. 2023;43:239-245.
     

     >> Share

     
     
131. CHIDIMATSU H, Tsunedomi R, Nakagami Y, Xu M, et al
     Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer.
     Anticancer Res. 2023;43:105-114.
     

     >> Share

     
     
132. PISTOLESI S, Fanelli GN, Giudice F, Garbini F, et al
     Cervical Adenocarcinoma: A Still Under-investigated Malignancy.
     Anticancer Res. 2023;43:53-58.
     

     >> Share

     
     
133. KIM MJ, Han Q, Bouvet M, Hoffman RM, et al
     Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal Carcinomatosis.
     Anticancer Res. 2023;43:19-24.
     

     >> Share

     
     December 2022
134. HAYASE S, Miyoshi N, Fujino S, Yasui M, et al
     Fibroblast Activation Protein and Tertiary Lymphoid Structure in Colorectal Cancer Recurrence.
     Anticancer Res. 2022;42:5897-5907.
     

     >> Share

     
     
135. LIM S, Kawai K, Nozawa H, Sasaki K, et al
     Low Expression of SNAI1 in Lymph Node Metastasis Indicates Delayed Recurrence of Colonic Cancer.
     Anticancer Res. 2022;42:5927-5935.
     

     >> Share

     
     
136. RUBIO CA, Lang-Schwarz C, Vieth M
     Further Study on Field Cancerization in the Human Colon.
     Anticancer Res. 2022;42:5891-5895.
     

     >> Share

     
     November 2022
137. DOI H, Fujiwara M, Beppu N, Yokoyama H, et al
     Neoadjuvant Modified Short-course Radiotherapy for Stage IV Rectal Cancer.
     Anticancer Res. 2022;42:5587-5595.
     

     >> Share

     
     
138. YUEH TC, Hung YC, Lee HT, Yang MD, et al
     Role of Matrix Metallopeptidase-2 Genotypes in Taiwanese Patients With Colorectal Cancer.
     Anticancer Res. 2022;42:5335-5342.
     

     >> Share

     
     
139. YAMAUCHI N, Matsuda T, Sawad R, Hasegawa H, et al
     Clinical Significance of Early Recurrence After Curative Resection of Colorectal Cancer.
     Anticancer Res. 2022;42:5553-5559.
     

     >> Share

     
     
140. TAKEDA K, Kikuchi Y, Sawada YU, Kumamoto T, et al
     Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases.
     Anticancer Res. 2022;42:5497-5505.
     

     >> Share

     
     
141. PARK YL, Cho SB, Park SY, Oh HH, et al
     Engulfment and Cell Motility 1 (ELMO1) Regulates Tumor Cell Behavior and Predicts Prognosis in Colorectal Cancer.
     Anticancer Res. 2022;42:5343-5355.
     

     >> Share

     
     
142. MEIROVITZ A, Baider L, Peretz T, Stephanos S, et al
     PTX Treatment of Colon Cancer: Mode of Action Based on Tumor Marker and Cytokine Kinetics.
     Anticancer Res. 2022;42:5487-5496.
     

     >> Share

     
     
143. TOMINAGA T, Nonaka T, Oyama S, Takamura Y, et al
     Gustave Roussy Immune Score for Predicting Postoperative Complications and Non-cancer Death in Elderly Patients With Colon Cancer.
     Anticancer Res. 2022;42:5643-5653.
     

     >> Share

     
     
144. KIM SH, Song SE, Baik H, Hur DY, et al
     15-Prostaglandin Dehydrogenase Inhibition Enhances Colon Cancer Metastasis by Up-regulation of Epithelial-to-Mesenchymal Transition Genes.
     Anticancer Res. 2022;42:5385-5396.
     

     >> Share

     
     October 2022
145. KATO S, Miyoshi N, Fujino S, Minami S, et al
     Combined Inflammation and Nutrition Factors Reinforce the Prognostic Prediction for Stage III Colorectal Cancer Patients.
     Anticancer Res. 2022;42:4989-4999.
     

     >> Share

     
     
146. CHOMICKI S, Chapet S, Drifa M, Ouaissi M, et al
     Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal Cancer.
     Anticancer Res. 2022;42:4833-4840.
     

     >> Share

     
     
147. OZATO Y, Masuda T, Kobayashi Y, Takao S, et al
     PRKRIP1, A Splicing Complex Factor, Is a Marker of Poor Prognosis in Colorectal Cancer.
     Anticancer Res. 2022;42:4701-4706.
     

     >> Share

     
     
148. RYU S, Kitagawa T, Goto K, Okamoto A, et al
     Intraoperative Holographic Guidance Using Virtual Reality and Mixed Reality Technology During Laparoscopic Colorectal Cancer Surgery.
     Anticancer Res. 2022;42:4849-4856.
     

     >> Share

     
     
149. ZHU D, Guo P, Jin XY, Zhang R, et al
     Long-chain Non-coding RNA MIR4435-2HG Expression Correlates With Size of Intestinal Polyps in Children and With Metastasis of Colon Cancer.
     Anticancer Res. 2022;42:4707-4714.
     

     >> Share

     
     
150. CZAPLA J, Drzyzga A, Matuszczak S, Pilny E, et al
     The Complex Composition of Trans-resveratrol, Quercetin, Vitamin E and Selenium Inhibits the Growth of Colorectal Carcinoma.
     Anticancer Res. 2022;42:4763-4772.
     

     >> Share

     
     
151. UTSUMI M, Inagaki M, Kitada K, Tokunaga N, et al
     Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
     Anticancer Res. 2022;42:4963-4971.
     

     >> Share

     
     
152. GERGER A, Eisterer W, Fuxius S, Bastian S, et al
     Retrospective Analysis of Treatment Pathways in Patients With BRAF(V600E)-mutant Metastatic Colorectal Carcinoma - MORSE(CRC).
     Anticancer Res. 2022;42:4773-4785.
     

     >> Share

     
     September 2022
153. RUBIO CA, Vieth M, Lang-Schwarz C
     Crypts in Asymmetric Branching in Patients With Ulcerative Colitis in Remission.
     Anticancer Res. 2022;42:4493-4497.
     

     >> Share

     
     
154. TAN C, Fisher OM, Huang L, Alzahrani N, et al
     Comparison of Microwave and Radiofrequency Ablation in the Treatment of Pulmonary Metastasis of Colorectal Cancer.
     Anticancer Res. 2022;42:4563-4571.
     

     >> Share

     
     
155. CRISTAUDO AT, Jennings SB, Morris DL
     Comparison of Proportion of Elevated Carcinoembryonic Antigen Levels in Patients With Appendiceal and Colorectal Adenocarcinoma: A Systematic Review and Meta-analysis.
     Anticancer Res. 2022;42:4217-4235.
     

     >> Share

     
     August 2022
156. KAWAMURA H, Honda M, Takano Y, Kinuta S, et al
     Prognostic Role of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Stage IV Colorectal Cancer.
     Anticancer Res. 2022;42:3921-3928.
     

     >> Share

     
     
157. KUBOTA Y, Han Q, Hamada K, Aoki Y, et al
     Long-term Stable Disease in a Rectal-cancer Patient Treated by Methionine Restriction With Oral Recombinant Methioninase and a Low-methionine Diet.
     Anticancer Res. 2022;42:3857-3861.
     

     >> Share

     
     
158. YOSHIDA K, Nishi K, Ishikura S, Nakabayashi K, et al
     Cancer Spheroid Proliferation Is Suppressed by a Novel Low-toxicity Compound, Pyra-Metho-Carnil, in a Context-independent Manner.
     Anticancer Res. 2022;42:3993-4001.
     

     >> Share

     
     July 2022
159. KATAOKA S, Arita T, Konishi H, Yamamoto Y, et al
     The Role of Inflammation-associated microRNA-4257 as a Promoter of Malignancy in Colorectal Cancer.
     Anticancer Res. 2022;42:3349-3360.
     

     >> Share

     
     
160. ESKELINEN M, Meklin J, Guimaraes DP, Selander T, et al
     Site-specific Performance of ColonView (CV) Fecal Immunochemical Test (FIT) With Differences Between Proximal and Distal Colorectal Adenoma.
     Anticancer Res. 2022;42:3557-3567.
     

     >> Share

     
     
161. MINAMI S, Miyoshi N, Fujino S, Kato S, et al
     The Geriatric Nutritional Risk Index as a Prognosis Predictor in Patients With Rectal Cancer Receiving Neoadjuvant Chemotherapy.
     Anticancer Res. 2022;42:3759-3766.
     

     >> Share

     
     
162. HIRAIDE T, Morita Y, Horikawa M, Sugiyama E, et al
     Saturated Fatty Acids in Cell Membrane Lipids Induce Resistance to 5-Fluorouracil in Colorectal Cancer Cells.
     Anticancer Res. 2022;42:3313-3324.
     

     >> Share

     
     June 2022
163. TOMINAGA T, Nonaka T, Oyama S, Takamura Y, et al
     Utility of Drain Fluid Culture and Gram Stain in Early Intervention for Occult Anastomotic Leakage in Colorectal Cancer.
     Anticancer Res. 2022;42:3091-3098.
     

     >> Share

     
     
164. OIKONOMAKIS I, Brodin D, Horer TM, Skoog P, et al
     Altered mRNA Expression Due to Rectal Perforation in a Porcine Model - A Pilot Study.
     Anticancer Res. 2022;42:2827-2833.
     

     >> Share

     
     May 2022
165. WU MH, Chen CH, Chen CP, Huang TL, et al
     Contribution of 5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase Genotypes to Colorectal Cancer in Taiwan.
     Anticancer Res. 2022;42:2375-2382.
     

     >> Share

     
     
166. TAMAGAWA H, Aoyama T, Numata M, Kazama K, et al
     Impact of Infectious Complications on Survival and Recurrence of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study.
     Anticancer Res. 2022;42:2763-2769.
     

     >> Share

     
     
167. SATO S, Mikayama YO, Shiozawa M, Nukada S, et al
     Chemotherapy-induced Reversion of Mutant RAS to Wild-type RAS in Metastatic Colorectal Cancer.
     Anticancer Res. 2022;42:2625-2635.
     

     >> Share

     
     
168. SONODA H, Kitamura C, Kano K, Anzai H, et al
     Changes in Lysophospholipid Components in Ulcerative Colitis and Colitis-associated Cancer.
     Anticancer Res. 2022;42:2461-2468.
     

     >> Share

     
     
169. TANIOKA H, Shimada K, Tsuji A, Kochi M, et al
     Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen.
     Anticancer Res. 2022;42:2675-2681.
     

     >> Share

     
     
170. PETRAKIS G, Mantso T, Koukourakis MI, Panayiotidis MI, et al
     Effectiveness of Hyperthermia as Monotherapy and Adjuvant Therapy Approaches Against an In Vitro Model of Colorectal Carcinoma.
     Anticancer Res. 2022;42:2363-2374.
     

     >> Share

     
     April 2022
171. ESKELINEN M, Meklin J, Guimaraes DP, Selander T, et al
     The ColonView (CV) Quick Test for Fecal Occult Blood Shows Significantly Higher Diagnostic Accuracy in Detecting Distal than Proximal Colorectal Cancer.
     Anticancer Res. 2022;42:1879-1891.
     

     >> Share

     
     
172. KATO A, Miyoshi N, Ohtsuru T, Sakai D, et al
     A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202).
     Anticancer Res. 2022;42:1859-1865.
     

     >> Share

     
     
173. HONG JK, Kim DY, Shin JS, Ryu YS, et al
     CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.
     Anticancer Res. 2022;42:1813-1819.
     

     >> Share

     
     
174. ISHIZAKI T, Katsumata K, Enomoto M, Mazaki J, et al
     Predictors of Lateral Pelvic Lymph Node Metastasis in Advanced Low Rectal Cancer Treated With Neoadjuvant Chemotherapy.
     Anticancer Res. 2022;42:2113-2121.
     

     >> Share

     
     
175. TACHIKAWA Y, Kawai K, Ozaki K, Nozawa H, et al
     CD133(+)HIF-1alpha(-) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer.
     Anticancer Res. 2022;42:2033-2043.
     

     >> Share

     
     
176. TOMITA K, Chiba N, Ochiai S, Gunji T, et al
     Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases.
     Anticancer Res. 2022;42:1997-2001.
     

     >> Share

     
     
177. KARAM E, Sindayigaya R, Giger-Pabst U, Gabriel M, et al
     Impact of Modern Management Strategies on the Clinical Outcome of Patients With Low Rectal Cancer - A Retrospective, Monocentric Cohort Study.
     Anticancer Res. 2022;42:1949-1963.
     

     >> Share

     
     March 2022
178. MAEDA A, Takahashi H, Harata S, Watanabe K, et al
     The Interaction Between Cancer-associated Fibroblasts and Cancer Cells Enhances Bcl-xL and Mcl-1 in Colorectal Cancer.
     Anticancer Res. 2022;42:1277-1288.
     

     >> Share

     
     
179. MATSUMURA K, Yamamura K, Miyamoto H, Hara Y, et al
     Highly Advanced Colorectal Liver Metastases Successfully Treated With Fluorouracil Plus Leucovorin Monotherapy and Microwave Ablation.
     Anticancer Res. 2022;42:1645-1651.
     

     >> Share

     
     
180. MATSUDA R, Kotsugi M, Nakase K, Morimoto T, et al
     Awake Craniotomy for Subcortical Brain Metastasis Beneath the Speech Center: A Technical Case Report.
     Anticancer Res. 2022;42:1641-1644.
     

     >> Share

     
     
181. KATAYAMA H, Tominaga T, Nonaka T, Araki M, et al
     Effect of Neoadjuvant Chemotherapy in Patients With Locally Advanced Rectal Cancer: A Multicenter Propensity Score-matched Analysis.
     Anticancer Res. 2022;42:1527-1533.
     

     >> Share

     
     
182. NACARKAHYA G, Borazan E, Horozoglu C, Yaylim I, et al
     Investigation of Long Non-coding RNAs H19 and LINC00675 in Colorectal Cancers in Terms of Histopathological Features and Correlations With Plasma Markers.
     Anticancer Res. 2022;42:1301-1306.
     

     >> Share

     
     February 2022
183. LIANG JA, Kuo YC, Chao KSC, Chen WT, et al
     High vs. Standard Radiotherapy Dose in Locally Advanced Rectal Adenocarcinoma Patients Treated With Neoadjuvant Long Course Chemoradiotherapy: A Population-based Study.
     Anticancer Res. 2022;42:1143-1150.
     

     >> Share

     
     
184. SHIRAISHI T, Ogawa H, Ozawa N, Suga K, et al
     Risk and Protective Factors for Postoperative Complications in Elderly Patients With Colorectal Cancer.
     Anticancer Res. 2022;42:1123-1130.
     

     >> Share

     
     
185. TOMIOKA K, Aoki T, Watanabe M, Enami Y, et al
     Increased Transumbilical Incision Complication Rates With Laparoscopic Colorectal Resection: A Single-center Propensity Score-matched Cohort Study.
     Anticancer Res. 2022;42:1115-1121.
     

     >> Share

     
     
186. DE FELICE F, Musio D, Iafrate F, Caponnetto S, et al
     Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis.
     Anticancer Res. 2022;42:991-1000.
     

     >> Share

     
     
187. KOYAMA M, Osada E, Akiyama N, Eto K, et al
     Effect of Thymidine Phosphorylase Gene Demethylation on Sensitivity to 5-Fluorouracil in Colorectal Cancer Cells.
     Anticancer Res. 2022;42:837-844.
     

     >> Share

     
     
188. HAGIWARA T, Sugimoto K, Momose H, Irie T, et al
     CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer.
     Anticancer Res. 2022;42:697-707.
     

     >> Share

     
     
189. GO G, Park HJ, Lee JH, Yun CW, et al
     Inhibitory Effect of Oxaliplatin-loaded Engineered Milk Extracellular Vesicles on Tumor Progression.
     Anticancer Res. 2022;42:857-866.
     

     >> Share

     
     January 2022
190. HWANG J, Park A, Kim C, Yu D, et al
     Suppression of DYRK1A/B Drives Endoplasmic Reticulum Stress-mediated Autophagic Cell Death Through Metabolic Reprogramming in Colorectal Cancer Cells.
     Anticancer Res. 2022;42:589-598.
     

     >> Share

     
     
191. MIYOSHI K, Sato E, Katsumata K, Fukushima G, et al
     CD15(+) Bone Marrow-derived Cells Are Regulators of Immune Response in ARG1-producing Colorectal Cancer Cells.
     Anticancer Res. 2022;42:459-470.
     

     >> Share

     
     
192. MULLER O, Sindayigaya R, Chomicki S, Karam E, et al
     Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal Adenocarcinoma.
     Anticancer Res. 2022;42:155-164.
     

     >> Share

     
     
193. MIYATA H, Akiyama Y, Iizuka A, Kondou R, et al
     Development of an Automatic Measurement Method for CD8 and PD-1 Positive T Cells Using Image Analysis Software.
     Anticancer Res. 2022;42:419-427.
     

     >> Share

     
     
194. BRESCIA A, Muttillo EM, Angelicone I, Madaffari I, et al
     The Role of Indocyanine Green in Laparoscopic Low Anterior Resections for Rectal Cancer Previously Treated With Chemo-radiotherapy: A Single-center Retrospective Analysis.
     Anticancer Res. 2022;42:211-216.
     

     >> Share

     
     December 2021
195. SHIBUTANI M, En W, Okazaki Y, Kashiwagi S, et al
     The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting.
     Anticancer Res. 2021;41:6211-6216.
     

     >> Share

     
     
196. ZENG X, Zhang L, Jia S, Lin T, et al
     Effects of Circulating 25(OH)D Status in Advanced Colorectal Cancer Patients Undergoing Chemotherapy: A Systematic Review.
     Anticancer Res. 2021;41:5903-5912.
     

     >> Share

     
     
197. MATSUHASHI N, Takahashi T, Tanaka C, Yawata K, et al
     Phase II Study of Preoperative Chemoradiotherapy With S-1 Plus Oxaliplatin for Locally Advanced Rectal Cancer (PerSeUS-RC01).
     Anticancer Res. 2021;41:6247-6257.
     

     >> Share

     
     November 2021
198. MAZAKI J, Katsumata K, Ohno Y, Udo R, et al
     A Novel Predictive Model for Anastomotic Leakage in Colorectal Cancer Using Auto-artificial Intelligence.
     Anticancer Res. 2021;41:5821-5825.
     

     >> Share

     
     
199. KAWAMURA H, Honda M, Takiguchi K, Kamiga T, et al
     Clinical Impact of Primary Tumor Site in Stage IV Colorectal Cancer: A Statewide Cohort Study.
     Anticancer Res. 2021;41:5693-5702.
     

     >> Share

     
     
200. TAGO T, Katsumata K, Udou R, Kasahara K, et al
     Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases.
     Anticancer Res. 2021;41:5539-5547.
     

     >> Share

     
     
201. ISHIZAWA M, Hirayu A, Makishima M
     Zinc Inhibits Cadherin 1 Expression Induced by 1alpha,25-Dihydroxyvitamin D3 in Colon Cancer Cells.
     Anticancer Res. 2021;41:5453-5459.
     

     >> Share

     
     
202. SUZUMURA H, Tsuruta M, Okabayashi K, Shigeta K, et al
     BAF57 Is a Potential Determinant of Colorectal Cancer Malignancy.
     Anticancer Res. 2021;41:5445-5452.
     

     >> Share

     
     
203. ROH SA, Kwon YH, Lee JL, Kim SK, et al
     SLAMF7 and TREM1 Mediate Immunogenic Cell Death in Colorectal Cancer Cells: Focus on Microsatellite Stability.
     Anticancer Res. 2021;41:5431-5444.
     

     >> Share

     
     
204. ADACHI Y, Yamamura K, Yumoto S, Higashi T, et al
     Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With Chemotherapy.
     Anticancer Res. 2021;41:5855-5861.
     

     >> Share

     
     
205. AKAHOSHI S, Yamamura K, Komohara Y, Yoshii D, et al
     A Case Report of Metachronous Multiple Adenosquamous Carcinoma of the Colon Over-expressing PD-L1 and a Literature Review.
     Anticancer Res. 2021;41:5847-5854.
     

     >> Share

     
     
206. FURUKAWA K, Onda S, Taniai T, Hamura R, et al
     Risk Factors and Overcoming Strategies of Surgical Site Infection After Hepatectomy for Colorectal Liver Metastases.
     Anticancer Res. 2021;41:5651-5656.
     

     >> Share

     
     
207. MASATSUNE S, Kimura K, Kashiwagi S, En W, et al
     Impact of Intraoperative Blood Loss and Blood Transfusion on the Prognosis of Colorectal Liver Metastasis Following Curative Resection.
     Anticancer Res. 2021;41:5617-5623.
     

     >> Share

     
     
208. OKAMOTO D, Matsuda T, Sawada R, Hasegawa H, et al
     Risk Factors for Complications Following Lateral Pelvic Lymph Node Dissection for Rectal Cancer.
     Anticancer Res. 2021;41:5599-5604.
     

     >> Share

     
     
209. MEKLIN J, Eskelinen M, Guimaraes DP, Selander T, et al
     The Automatically Analyzed (AA) ColonView (CV) Quick Test for Fecal Occult Blood Shows Higher Diagnostic Accuracy in Detection of Colorectal Adenoma than Visually Analyzed Tests.
     Anticancer Res. 2021;41:5517-5525.
     

     >> Share

     
     October 2021
210. SATO S, Shiozawa M, Nukada S, Iguchi K, et al
     Preoperative Pre-albumin Concentration as a Predictor of Short-term Outcomes in Elderly Patients With Colorectal Cancer.
     Anticancer Res. 2021;41:5195-5202.
     

     >> Share

     
     
211. ATSUMI Y, Numata M, Kazama K, Kawahara S, et al
     Can D3 Lymph Node Dissection for Patients With Colon Cancer With a Poor C-Reactive Protein/Albumin Ratio Improve Survival Outcomes?
     Anticancer Res. 2021;41:5097-5106.
     

     >> Share

     
     
212. MEKLIN J, Eskelinen M, Guimaraes DP, Selander T, et al
     The New Generation Immunochemical Test for Fecal Occult Blood (ColonView Quick Test) Shows a High Diagnostic Accuracy in Colorectal Cancer Detection.
     Anticancer Res. 2021;41:5071-5079.
     

     >> Share

     
     
213. NEUPANE P, Mimura K, Nakajima S, Okayama H, et al
     The Expression of Immune Checkpoint Receptors and Ligands in the Colorectal Cancer Tumor Microenvironment.
     Anticancer Res. 2021;41:4895-4905.
     

     >> Share

     
     
214. TADA Y, Matsumi Y, Hara K, Miyauchi W, et al
     Infiltration of CD204-overexpressing Macrophages Contributes to the Progression of Stage II and III Colorectal Cancer.
     Anticancer Res. 2021;41:4857-4865.
     

     >> Share

     
     
215. MIYAMOTO S, Fukui T, Horitani S, Tanimura Y, et al
     Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis.
     Anticancer Res. 2021;41:4789-4799.
     

     >> Share

     
     
216. OZLUK E, Coppola D, Mohammad IZ, Islam T, et al
     Ethylmalonic Encephalopathy 1 Protein Is Increased in Colorectal Adenocarcinoma.
     Anticancer Res. 2021;41:4719-4723.
     

     >> Share

     
     
217. SATO K, Miura T, Sakamoto Y, Morohashi H, et al
     Fascial Organisation and Lymphatic Systems Around the Pelvic Floor: A Literature Review.
     Anticancer Res. 2021;41:4705-4714.
     

     >> Share

     
     
218. IIDA T, Murono K, Shiratori H, Nozawa H, et al
     Impact of Inferior Mesenteric Artery Occlusion on the Calibre of Collateral Arteries of the Colon.
     Anticancer Res. 2021;41:5189-5193.
     

     >> Share

     
     
219. CHUNG YC, Ku YL, Chiang HC, Liu WC, et al
     Antibody to Interleukin-6 Receptor Inhibits In Vivo Growth of Human Colorectal Carcinoma Cell Xenografts.
     Anticancer Res. 2021;41:4907-4916.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share